MANAGEMENT OF CONDYLOMATA ACUMINATA WITH ALFERON-N INJECTION, INTERFERON ALFA-N3 (HUMAN-LEUKOCYTE DERIVED)

被引：23
|
作者：
FRIEDMANKIEN, A [1 ]
机构：
[1] NYU, MED CTR, DEPT DERMATOL, NEW YORK, NY 10016 USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 1995年 / 172卷 / 04期
关键词：
D O I：
10.1016/0002-9378(95)90404-2
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
[No abstract available]
引用
收藏
页码：1359 / 1368
页数：10
相关论文
共 26 条
  • [11] Treatment of chronic hepatitis C with interferon alfa-n3: A multicenter, randomized, open-label trial
    Simon, DM
    Gordon, SC
    Kaplan, AM
    Koff, RS
    Regenstein, F
    Everson, G
    Lee, YM
    Weiner, F
    Silverman, A
    Plasse, T
    Fedorczyk, D
    Liao, MJ
    HEPATOLOGY, 1997, 25 (02) : 445 - 448
  • [12] Extravascular administration of interferon alfa-n3 increases serum exposure and 2-5(A) synthetase activity
    Sturgill, MG
    Rashidbaigi, A
    Liao, MJ
    Zhao, XX
    Hua, J
    Trout, R
    Knill, JR
    Grasing, KW
    JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (06): : 606 - 615
  • [13] Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: Results of a randomized, controlled trial
    Sostegni, R
    Ghisetti, V
    Pittaluga, F
    Marchiaro, G
    Rocca, G
    Borghesio, E
    Rizzetto, M
    Saracco, G
    HEPATOLOGY, 1998, 28 (02) : 341 - 346
  • [14] ISOLATION AND PROPERTIES OF RECOMBINANT DNA-PRODUCED HUMAN-LEUKOCYTE INTERFERON-ALPHA-I1 AND INTERFERON-ALPHA-N
    EREMASHVILI, MR
    BORUKHOV, SI
    BAKHUTASHVILI, VI
    NARODITSKAYA, VA
    CHISTOSERDOV, AY
    EVDONINA, LV
    CHERNOVSKAYA, TV
    SKVORTSOVA, MA
    STERKIN, VE
    IZOTOVA, LS
    STRONGIN, AY
    BIOCHEMISTRY-MOSCOW, 1988, 53 (01) : 132 - 139
  • [15] 3-(ALKYLTHIO)-N-HYDROXYSUCCINIMIDE DERIVATIVES - POTENT INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE
    GROUTAS, WC
    VENKATARAMAN, R
    BRUBAKER, MJ
    EPP, JB
    CHONG, LS
    STANGA, MA
    MCCLENAHAN, JJ
    TAGUSAGAWA, F
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1164 (03) : 283 - 288
  • [16] Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: Evidence for drug safety, tolerance, and antiviral activity
    Skillman, DR
    Malone, JL
    Decker, CF
    Wagner, KF
    Mapou, RL
    Liao, MJ
    Testa, D
    Meltzer, MS
    JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05): : 1107 - 1114
  • [17] Sequential versus concomitant administration of ribavirin and interferon alfa-N3 in patients with chronic hepatitis C not responding to interferon alone. Results of a randomized controlled trial.
    Sostegni, R
    Ghisetti, V
    Pittaluga, F
    Marchiaro, G
    Rocca, G
    Borghesio, E
    Rizzetto, M
    Saracco, G
    GASTROENTEROLOGY, 1998, 114 (04) : A1344 - A1344
  • [18] SYNTHETIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE .3. PEPTIDES WITH ALKYL-GROUPS AT THE N-TERMINUS OR C-TERMINUS - NONTOXIC COMPETITIVE INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE
    LENTINI, A
    FARCHIONE, F
    TERNAI, B
    KREUAONGARJNUKOOL, N
    TOVIVICH, P
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1987, 368 (04): : 369 - 378
  • [19] IONIC INHIBITORS OF HUMAN-LEUKOCYTE ELASTASE - PYRIDINIUM AND PHENYL CARBOXYLATE DERIVATIVES OF 3-ALKYL-N-HYDROXYSUCCINIMIDE
    GROUTAS, WC
    STANGA, MA
    CASTRISOS, JC
    SCHATZ, EJ
    BRUBAKER, MJ
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (10) : 886 - 888
  • [20] Sequence analysis of hepatitis C virus subtype 1b NS5A gene segment from patients treated with human leukocyte-derived interferon alfa-N3.
    Hussain, M
    Ni, DZ
    Gill, DS
    Fedorczyk, D
    Liao, MJ
    HEPATOLOGY, 1997, 26 (04) : 714 - 714
123